Verona Pharma: Q4 Earnings Insights

 

Verona Pharma VRNA reported its Q4 earnings results on Thursday, March 3, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Verona Pharma beat estimated earnings by 16.67%, reporting an EPS of $-0.4 versus an estimate of $-0.48.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.53 which was followed by a 1.74% drop in the share price the next day.

 

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

VRNA Logo
VRNAVerona Pharma PLC
$76.341.71%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
99.34
Growth
Not Available
Quality
Not Available
Value
6.15
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Comments
Loading...